Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27 th...
Saved in:
Published in | Scientific reports Vol. 8; no. 1; pp. 5804 - 12 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
11.04.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27
th
, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787–0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576–0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556–0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620–1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818–0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383–1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449–0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475–1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD. |
---|---|
AbstractList | We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27
th
, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787–0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576–0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556–0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620–1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818–0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383–1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449–0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475–1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD. We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer's disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787-0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576-0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556-0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620-1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818-0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383-1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449-0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475-1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD.We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer's disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787-0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576-0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556-0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620-1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818-0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383-1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449-0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475-1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD. We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer's disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27 , 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787-0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576-0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556-0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620-1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818-0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383-1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449-0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475-1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD. We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849, 95% CI = 0.787–0.916, p = 0.000), AD (k = 14, aRR = 0.719, 95% CI = 0.576–0.899, p = 0.004), and MCI (k = 6, aRR = 0.737, 95% CI = 0.556–0.976, p = 0.033), but no meaningful effects on incident VaD (k = 3, aRR = 1.012, 95% CI = 0.620–1.652, p = 0.961). Subgroup analysis suggested that hydrophilic statins were associated with reduced risk of all-caused dementia (aRR = 0.877; CI = 0.818–0.940; p = 0.000) and possibly lower AD risk (aRR = 0.619; CI = 0.383–1.000; p = 0.050). Lipophilic statins were associated with reduced risk of AD (aRR = 0.639; CI = 0.449–0.908; p = 0.013) but not all-caused dementia (aRR = 0.738; CI = 0.475–1.146; p = 0.176). In conclusion, our meta-analysis suggests that the use of statins may reduce the risk of all-type dementia, AD, and MCI, but not of incident VaD. |
ArticleNumber | 5804 |
Author | Tseng, Ping-Tao Chu, Che-Sheng Lin, Pao-Yen Tang, Chia-Hung Fernandes, Brisa S. Stubbs, Brendon Chen, Tien-Yu Li, Dian-Jeng Carvalho, Andre F. Herrmann, Nathan Yang, Wei-Cheng Wu, Ching-Kuan Veronese, Nicola Chen, Yen-Wen |
Author_xml | – sequence: 1 givenname: Che-Sheng surname: Chu fullname: Chu, Che-Sheng organization: Department of Psychiatry, Kaohsiung Veterans General Hospital, Center for Geriatric and Gerontology, Kaohsiung Veterans General Hospital – sequence: 2 givenname: Ping-Tao orcidid: 0000-0001-5761-7800 surname: Tseng fullname: Tseng, Ping-Tao organization: Department of Psychiatry, Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai’s Home, WinShine Clinics in Specialty of Psychiatry – sequence: 3 givenname: Brendon surname: Stubbs fullname: Stubbs, Brendon organization: Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, De Crespigny Park, Faculty of Health, Social Care and Education, Anglia Ruskin University – sequence: 4 givenname: Tien-Yu surname: Chen fullname: Chen, Tien-Yu organization: Department of Psychiatry, Tri-Service General Hospital; School of Medicine, National Defense Medical Center, Institute of Brain Science, National Yang-Ming University – sequence: 5 givenname: Chia-Hung surname: Tang fullname: Tang, Chia-Hung organization: Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare – sequence: 6 givenname: Dian-Jeng orcidid: 0000-0002-6036-045X surname: Li fullname: Li, Dian-Jeng organization: Department of Addiction Science, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Graduate institute of Medicine, College of Medicine, Kaohsiung Medical University – sequence: 7 givenname: Wei-Cheng surname: Yang fullname: Yang, Wei-Cheng organization: Department of Adult Psychiatry, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital – sequence: 8 givenname: Yen-Wen surname: Chen fullname: Chen, Yen-Wen organization: Prospect clinic for otorhinolaryngology & neurology – sequence: 9 givenname: Ching-Kuan surname: Wu fullname: Wu, Ching-Kuan organization: Center for Geriatric and Gerontology, Kaohsiung Veterans General Hospital – sequence: 10 givenname: Nicola surname: Veronese fullname: Veronese, Nicola organization: National Research Council, Neuroscience Institute, Aging Branch – sequence: 11 givenname: Andre F. surname: Carvalho fullname: Carvalho, Andre F. organization: Department of Psychiatry, University of Toronto, Centre for Addiction & Mental Health (CAMH) – sequence: 12 givenname: Brisa S. surname: Fernandes fullname: Fernandes, Brisa S. organization: IMPACT Strategic Research Centre, School of Medicine, and Barwon Health, Deakin University, Laboratory of Calcium Binding Proteins in the Central Nervous System, Department of Biochemistry, Federal University of Rio Grande do Sul, Porto – sequence: 13 givenname: Nathan surname: Herrmann fullname: Herrmann, Nathan organization: Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Psychiatry, University of Toronto – sequence: 14 givenname: Pao-Yen surname: Lin fullname: Lin, Pao-Yen email: py1029@adm.cgmh.org.tw organization: Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Institute for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29643479$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uctu1DAUtVARLaU_wAJZYsMm4Gdis0CqKl5SJTZ0bTnOnalLYg-2Z6r5e5xJKaWLemPL53HP1XmJjkIMgNBrSt5TwtWHLKjUqiFUNUwwoRr1DJ0wImTDOGNHD97H6CznG1KPZFpQ_QIdM90KLjp9gsarDDiucC62-JCxDQMu14CTz7_m_wEmCMXbAzD5ccAuroMvfgfYTxvr04x_xOc473OBqbo4nGDn4XaRQLGNDXbcZ59foecrO2Y4u7tP0dWXzz8vvjWXP75-vzi_bJwUpDRgFRkkpUIoRlrueN-LrhtaTjjjVBLXaUd1T-jANGl7AN3SXq8ks0y2vNX8FH1afDfbfoLB1YTJjmaT_GTT3kTrzf9I8NdmHXdGKi1b2lWDd3cGKf7eQi5m8tnBONoAcZsNI0yITnDNKvXtI-pN3Ka68IHFtWZdNxu-eZjoPsrfIiqBLQSXYs4JVvcUSsxcuFkKN7VwcyjcqCpSj0TOzz3GeSs_Pi3lizTXOWEN6V_sJ1R_AMohvs0 |
CitedBy_id | crossref_primary_10_1016_j_neuro_2018_11_012 crossref_primary_10_1016_j_eprac_2023_03_004 crossref_primary_10_2174_1566524020666200619125404 crossref_primary_10_1016_j_jacl_2020_10_007 crossref_primary_10_1093_eurjpc_zwab208 crossref_primary_10_1111_joim_13227 crossref_primary_10_1016_j_heliyon_2024_e30523 crossref_primary_10_1001_jamanetworkopen_2019_20780 crossref_primary_10_5334_gh_934 crossref_primary_10_1016_j_ibneur_2024_07_002 crossref_primary_10_1016_j_rechem_2021_100230 crossref_primary_10_3390_molecules25225439 crossref_primary_10_1055_s_0042_1759580 crossref_primary_10_1109_JTEHM_2023_3317189 crossref_primary_10_1002_acn3_51516 crossref_primary_10_1038_s41598_021_94618_2 crossref_primary_10_1161_ATV_0000000000000164 crossref_primary_10_1016_j_jacc_2019_09_040 crossref_primary_10_1186_s12916_021_02009_1 crossref_primary_10_2478_abm_2022_0009 crossref_primary_10_1177_08919887211044747 crossref_primary_10_1016_j_cct_2019_02_007 crossref_primary_10_3389_fnins_2021_653651 crossref_primary_10_3390_healthcare7040161 crossref_primary_10_1016_j_heliyon_2023_e19735 crossref_primary_10_1039_D2FO01199A crossref_primary_10_1111_joim_12838 crossref_primary_10_1080_00325481_2019_1657776 crossref_primary_10_1016_j_atherosclerosis_2025_119159 crossref_primary_10_1002_14651858_CD008900_pub3 crossref_primary_10_1186_s12944_021_01534_5 crossref_primary_10_1016_j_cpcardiol_2021_100960 crossref_primary_10_3389_fnagi_2022_968039 crossref_primary_10_1155_2020_4935831 crossref_primary_10_3233_JAD_201462 crossref_primary_10_1161_CIRCRESAHA_118_312782 crossref_primary_10_1111_psyg_12869 crossref_primary_10_1093_gerona_glab220 crossref_primary_10_47855_jal9020_2024_3_1 crossref_primary_10_1001_jama_2020_8390 crossref_primary_10_1016_j_cjco_2020_06_002 crossref_primary_10_1080_14740338_2020_1796966 crossref_primary_10_1136_bmjno_2023_000541 crossref_primary_10_1002_ibra_12018 crossref_primary_10_3390_biomedicines8110457 crossref_primary_10_1111_ggi_14360 crossref_primary_10_1111_joim_13134 crossref_primary_10_1183_16000617_0102_2019 crossref_primary_10_1002_jcb_27761 crossref_primary_10_1016_j_bbi_2023_04_017 crossref_primary_10_1016_j_brainresbull_2020_04_010 crossref_primary_10_1016_j_arr_2019_100962 crossref_primary_10_1016_j_ebiom_2018_10_021 crossref_primary_10_1016_j_pcad_2023_02_007 crossref_primary_10_1021_acsbiomaterials_4c00911 crossref_primary_10_3390_biomedicines9010072 crossref_primary_10_7759_cureus_35756 crossref_primary_10_1038_s41598_019_47956_1 crossref_primary_10_1016_j_lanwpc_2023_101006 crossref_primary_10_3390_ijms21093226 crossref_primary_10_1016_j_pnpbp_2025_111282 crossref_primary_10_1007_s13311_020_00853_2 crossref_primary_10_1007_s40266_024_01139_4 crossref_primary_10_1097_HCO_0000000000001003 crossref_primary_10_1016_j_bja_2020_01_010 crossref_primary_10_1097_CRD_0000000000000359 crossref_primary_10_5604_01_3001_0015_4805 crossref_primary_10_1016_j_phrs_2024_107446 crossref_primary_10_1161_STR_0000000000000476 crossref_primary_10_1186_s12951_021_00864_x crossref_primary_10_14283_jpad_2022_44 crossref_primary_10_1161_STROKEAHA_122_038265 crossref_primary_10_3390_brainsci12101290 crossref_primary_10_1093_cvr_cvab032 crossref_primary_10_2174_0929867327666200312114223 crossref_primary_10_3233_JAD_200960 crossref_primary_10_3390_cells12131700 crossref_primary_10_3390_ijms232415983 crossref_primary_10_12997_jla_2022_11_2_133 crossref_primary_10_1007_s00228_022_03322_1 crossref_primary_10_1093_ndt_gfab182 crossref_primary_10_18087_cardio_2505 crossref_primary_10_1038_s41398_018_0336_y crossref_primary_10_1097_NRL_0000000000000448 crossref_primary_10_1016_j_brainres_2020_147115 crossref_primary_10_1007_s43440_021_00293_5 crossref_primary_10_1038_s41598_020_63035_2 crossref_primary_10_1016_j_neuroscience_2024_12_059 crossref_primary_10_1097_MD_0000000000013679 crossref_primary_10_1093_bioinformatics_btaa451 crossref_primary_10_1186_s12933_024_02392_y crossref_primary_10_3390_ijms23179777 crossref_primary_10_1186_s13195_023_01360_0 crossref_primary_10_3233_JAD_240270 crossref_primary_10_1007_s11883_024_01255_x crossref_primary_10_1016_j_isci_2023_106740 crossref_primary_10_2196_52107 crossref_primary_10_3389_fnagi_2021_647990 crossref_primary_10_1016_j_jacc_2022_05_041 crossref_primary_10_1080_13543784_2020_1795127 crossref_primary_10_3389_fphar_2025_1473796 crossref_primary_10_1007_s10654_022_00909_x crossref_primary_10_1016_j_gene_2020_145316 crossref_primary_10_1038_s41419_022_04784_y crossref_primary_10_1177_1747493019873706 crossref_primary_10_3389_fpsyt_2019_00103 crossref_primary_10_31083_j_jin2302040 |
Cites_doi | 10.1592/phco.23.6.726.32184 10.1016/j.jns.2009.02.352 10.1016/S0140-6736(00)03155-X 10.1186/s13195-016-0188-8 10.1016/j.jalz.2017.06.964 10.1016/j.arr.2015.04.006 10.18865/ed.25.3.345 10.1001/archneur.59.3.378 10.1111/ggi.12044 10.1111/jgs.13482 10.1371/journal.pone.0088434 10.1016/j.neulet.2007.02.023 10.1212/01.wnl.0000319647.15752.7b 10.1016/S0140-6736(03)12948-0 10.1016/S1474-4422(16)30235-6 10.1016/j.jalz.2011.03.008 10.1007/s40266-015-0295-4 10.1136/jech.2009.100826 10.1046/j.1532-5415.2002.50515.x 10.1007/s00228-014-1801-z 10.1001/archpsyc.62.2.217 10.1016/j.jalz.2016.07.150 10.1016/j.neuroscience.2016.04.053 10.1002/pds.3381 10.1001/jamaneurol.2016.3783 10.1001/archneur.62.7.1047 10.1111/jgs.12414 10.1016/j.amjmed.2006.07.033 10.1124/pr.57.2.4 10.1006/nbdi.2001.0422 10.1038/sj.tpj.6500384 10.1002/gps.2604 10.7326/0003-4819-159-10-201311190-00007 10.1136/jnnp.2008.150433 10.1016/j.jstrokecerebrovasdis.2010.11.002 10.1212/WNL.34.7.939 10.1001/jama.283.24.3230 10.1016/j.jclinepi.2017.09.013 10.1016/S0140-6736(02)09327-3 10.3233/JAD-2010-091570 10.1371/journal.pmed.0020018 10.1111/j.1600-0404.2006.00689.x 10.1111/jgs.13907 10.2337/dcS15-3022 10.1001/archneur.59.2.223 10.1186/1741-7015-5-20 10.1037/1082-989X.11.2.193 10.1016/j.jclinepi.2005.12.012 10.1093/gerona/57.7.M414 10.1186/s13195-017-0237-y 10.1016/j.jalz.2009.04.415 10.1111/j.1532-5415.2010.02906.x 10.1111/j.1365-2125.2008.03308.x 10.1007/s11606-014-3115-3 10.1016/S0022-510X(02)00290-3 10.1136/bmj.c2197 10.1136/bmj.315.7109.629 10.1007/s12603-017-0870-y 10.1159/000073981 10.1001/archneur.61.5.705 10.1016/j.neurobiolaging.2014.03.037 10.1017/S1041610297004717 10.1212/01.wnl.0000288181.00826.63 10.1212/01.wnl.0000277657.95487.1c 10.1212/01.WNL.0000142963.90204.58 10.1159/000099037 10.1007/s00228-014-1800-0 10.4103/1008-682X.168687 10.1186/1741-7015-12-51 10.1159/000095679 10.3233/JAD-2010-100180 10.1371/journal.pmed.1000100 10.3390/nu6104452 10.1016/j.mayocp.2013.07.013 10.1016/S0140-6736(02)11600-X 10.2174/156720508785132316 10.1212/01.wnl.0000279333.77404.d7 10.1161/CIRCRESAHA.116.308537 10.1016/j.jalz.2009.07.067 10.3233/JAD-2012-120064 10.1212/WNL.0000000000004818 10.2147/CIA.S40405 10.1093/gerona/glx234 |
ContentType | Journal Article |
Copyright | The Author(s) 2018 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2018 – notice: 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM |
DOI | 10.1038/s41598-018-24248-8 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 12 |
ExternalDocumentID | PMC5895617 29643479 10_1038_s41598_018_24248_8 |
Genre | Journal Article |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IPNFZ KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RIG RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c540t-ea80d5114482063c3bb477d630323150c79c19b01d2906bee961b9f52a2563693 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Thu Aug 21 18:01:39 EDT 2025 Mon Jul 21 10:50:31 EDT 2025 Wed Aug 13 02:51:07 EDT 2025 Wed Feb 19 02:43:07 EST 2025 Tue Jul 01 02:50:55 EDT 2025 Thu Apr 24 22:52:32 EDT 2025 Fri Feb 21 02:38:27 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-ea80d5114482063c3bb477d630323150c79c19b01d2906bee961b9f52a2563693 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-5761-7800 0000-0002-6036-045X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-018-24248-8 |
PMID | 29643479 |
PQID | 2023992777 |
PQPubID | 2041939 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895617 proquest_miscellaneous_2024474392 proquest_journals_2023992777 pubmed_primary_29643479 crossref_primary_10_1038_s41598_018_24248_8 crossref_citationtrail_10_1038_s41598_018_24248_8 springer_journals_10_1038_s41598_018_24248_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-11 |
PublicationDateYYYYMMDD | 2018-04-11 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Bitzur (CR75) 2016; 39 Samaras (CR76) 2015; 63 Ott (CR52) 2015; 30 Zigman (CR47) 2007; 416 Vuletic (CR64) 2006; 22 McKhann (CR79) 1984; 34 Huedo-Medina, Sanchez-Meca, Marin-Martinez, Botella (CR83) 2006; 11 Rea (CR22) 2005; 62 Chouinard-Watkins, Plourde (CR71) 2014; 6 Zhou, Teramukai, Fukushima (CR35) 2007; 23 Kandiah, Feldman (CR60) 2009; 283 Benito-Leon, Louis, Vega, Bermejo-Pareja (CR20) 2010; 21 CR78 Zandi (CR25) 2005; 62 Haag, Hofman, Koudstaal, Stricker, Breteler (CR10) 2009; 80 Szwast (CR50) 2007; 69 Birmingham (CR69) 2015; 71 Sparks (CR16) 2008; 5 Rockwood (CR14) 2002; 59 Smeeth, Douglas, Hall, Hubbard, Evans (CR24) 2009; 67 Zamrini, McGwin, Roseman (CR17) 2004; 23 Song, Nie, Xu, Zhang, Wu (CR32) 2013; 13 Petersen (CR80) 1997; 9 Shah (CR4) 2016; 15 Mangravite, Thorn, Krauss (CR67) 2006; 6 CR2 Hajjar, Schumpert, Hirth, Wieland, Eleazer (CR11) 2002; 57 Rodriguez, Dodge, Birzescu, Stoehr, Ganguli (CR15) 2002; 50 Zissimopoulos, Barthold, Brinton, Joyce (CR65) 2017; 74 Reitz, Tang, Luchsinger, Mayeux (CR23) 2004; 61 Chitnis (CR40) 2015; 32 Wolozin (CR49) 2007; 5 Birmingham (CR68) 2015; 71 Prince (CR1) 2016; 8 Steenland, Zhao, Goldstein, Levey (CR54) 2013; 61 Li (CR13) 2010; 58 CR82 Schneider, Mielke, Yasar, Carlson (CR45) 2009; 5 Zhang, Fan, Wang, Wang, Li (CR61) 2013; 8 Parikh (CR44) 2011; 26 Yaffe, Barrett-Connor, Lin, Grady (CR48) 2002; 59 Ancelin (CR18) 2012; 30 McGuinness, Passmore (CR5) 2010; 20 Pedrini (CR7) 2005; 2 Etminan, Gill, Samii (CR31) 2003; 23 Sinyavskaya (CR66) 2017 Poirier (CR70) 2014; 35 Kuiper (CR72) 2015; 22 Murphy, Holmes, Brooks (CR74) 2017; 21 Swiger, Manalac, Blumenthal, Blaha, Martin (CR33) 2013; 88 Li (CR51) 2007; 69 Ryglewicz (CR55) 2002; 203-204 Ostrowski (CR6) 2016; 329 Glynn, Schneeweiss, Wang, Levin, Avorn (CR28) 2006; 59 Hippisley-Cox, Coupland (CR43) 2010; 340 Beydoun (CR42) 2011; 65 Hendrie (CR41) 2015; 25 Gnjidic (CR39) 2016; 64 Barreto, Demougeot, Vellas, Rolland (CR73) 2017 (CR56) 2002; 360 Refolo (CR59) 2001; 8 Shepherd (CR57) 2002; 360 Sever (CR58) 2003; 361 Dale, White, Henyan, Kluger, Coleman (CR84) 2007; 120 Oesterle, Laufs, Liao (CR62) 2017; 120 Macedo (CR53) 2014; 12 Liberati (CR77) 2009; 6 Egger, Davey Smith, Schneider, Minder (CR86) 1997; 315 Geifman, Brinton, Kennedy, Schneider, Butte (CR29) 2017; 9 Solomon, Soininen, Laatikainen, Tuomilehto, Kivipelto (CR46) 2009; 5 Chen (CR38) 2014; 9 Arvanitakis (CR19) 2008; 70 Hawkins, Davis (CR63) 2005; 57 Richardson (CR37) 2013; 159 Jick, Zornberg, Jick, Seshadri, Drachman (CR12) 2000; 356 Brauner, Muir, Sachs (CR27) 2000; 283 Sparks (CR26) 2006; 185 Wimo (CR3) 2017; 13 Cramer, Haan, Galea, Langa, Kalbfleisch (CR9) 2008; 71 Wong, Lin, Boudreau, Devine (CR34) 2013; 22 Li (CR21) 2004; 63 Hemkens (CR30) 2018; 93 Harding AC (CR36) 2017; 13 Tan (CR85) 2017; 19 Albert (CR81) 2011; 7 Bettermann (CR8) 2012; 21 A Oesterle (24248_CR62) 2017; 120 B Wolozin (24248_CR49) 2007; 5 BT Hawkins (24248_CR63) 2005; 57 N Geifman (24248_CR29) 2017; 9 MS Albert (24248_CR81) 2011; 7 K Bettermann (24248_CR8) 2012; 21 L Smeeth (24248_CR24) 2009; 67 K Steenland (24248_CR54) 2013; 61 S Vuletic (24248_CR64) 2006; 22 G Li (24248_CR21) 2004; 63 A Wimo (24248_CR3) 2017; 13 D Gnjidic (24248_CR39) 2016; 64 J Shepherd (24248_CR57) 2002; 360 M Etminan (24248_CR31) 2003; 23 I Hajjar (24248_CR11) 2002; 57 PP Zandi (24248_CR25) 2005; 62 24248_CR2 TB Huedo-Medina (24248_CR83) 2006; 11 G Li (24248_CR13) 2010; 58 J Poirier (24248_CR70) 2014; 35 KJ Swiger (24248_CR33) 2013; 88 H Shah (24248_CR4) 2016; 15 K Richardson (24248_CR37) 2013; 159 LM Mangravite (24248_CR67) 2006; 6 JM Chen (24248_CR38) 2014; 9 SJ Szwast (24248_CR50) 2007; 69 K Rockwood (24248_CR14) 2002; 59 MA Beydoun (24248_CR42) 2011; 65 E Zamrini (24248_CR17) 2004; 23 B McGuinness (24248_CR5) 2010; 20 DL Sparks (24248_CR26) 2006; 185 R Bitzur (24248_CR75) 2016; 39 WB Zigman (24248_CR47) 2007; 416 N Kandiah (24248_CR60) 2009; 283 AS Chitnis (24248_CR40) 2015; 32 24248_CR82 Y Song (24248_CR32) 2013; 13 C Reitz (24248_CR23) 2004; 61 AF Macedo (24248_CR53) 2014; 12 WB Wong (24248_CR34) 2013; 22 JM Zissimopoulos (24248_CR65) 2017; 74 SM Ostrowski (24248_CR6) 2016; 329 J Hippisley-Cox (24248_CR43) 2010; 340 DL Sparks (24248_CR16) 2008; 5 RJ Glynn (24248_CR28) 2006; 59 R Chouinard-Watkins (24248_CR71) 2014; 6 PS Barreto (24248_CR73) 2017 K Yaffe (24248_CR48) 2002; 59 BR Ott (24248_CR52) 2015; 30 A Solomon (24248_CR46) 2009; 5 HC Hendrie (24248_CR41) 2015; 25 MD Haag (24248_CR10) 2009; 80 DJ Brauner (24248_CR27) 2000; 283 S Pedrini (24248_CR7) 2005; 2 M Prince (24248_CR1) 2016; 8 H Jick (24248_CR12) 2000; 356 A Liberati (24248_CR77) 2009; 6 G McKhann (24248_CR79) 1984; 34 K Samaras (24248_CR76) 2015; 63 NM Parikh (24248_CR44) 2011; 26 M Egger (24248_CR86) 1997; 315 24248_CR78 BK Birmingham (24248_CR68) 2015; 71 TD Rea (24248_CR22) 2005; 62 EB Schneider (24248_CR45) 2009; 5 P Tan (24248_CR85) 2017; 19 Z Arvanitakis (24248_CR19) 2008; 70 G Li (24248_CR51) 2007; 69 Heart Protection Study Collaborative (24248_CR56) 2002; 360 LM Refolo (24248_CR59) 2001; 8 KM Dale (24248_CR84) 2007; 120 B Zhou (24248_CR35) 2007; 23 RC Petersen (24248_CR80) 1997; 9 EG Rodriguez (24248_CR15) 2002; 50 PS Sever (24248_CR58) 2003; 361 JS Kuiper (24248_CR72) 2015; 22 YY Zhang (24248_CR61) 2013; 8 J Benito-Leon (24248_CR20) 2010; 21 D Ryglewicz (24248_CR55) 2002; 203-204 BK Birmingham (24248_CR69) 2015; 71 C Cramer (24248_CR9) 2008; 71 J Murphy (24248_CR74) 2017; 21 ML Ancelin (24248_CR18) 2012; 30 SC Harding AC (24248_CR36) 2017; 13 L Sinyavskaya (24248_CR66) 2017 LG Hemkens (24248_CR30) 2018; 93 |
References_xml | – volume: 23 start-page: 726 year: 2003 end-page: 730 ident: CR31 article-title: The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies publication-title: Pharmacotherapy doi: 10.1592/phco.23.6.726.32184 – volume: 283 start-page: 230 year: 2009 end-page: 234 ident: CR60 article-title: Therapeutic potential of statins in Alzheimer’s disease publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.02.352 – volume: 356 start-page: 1627 year: 2000 end-page: 1631 ident: CR12 article-title: Statins and the risk of dementia publication-title: Lancet doi: 10.1016/S0140-6736(00)03155-X – volume: 8 start-page: 23 year: 2016 ident: CR1 article-title: Recent global trends in the prevalence and incidence of dementia, and survival with dementia publication-title: Alzheimers Res Ther doi: 10.1186/s13195-016-0188-8 – volume: 13 start-page: 736 year: 2017 end-page: 737 ident: CR36 article-title: Impact of statin use on cognitive decline in healthy women from a long-term longitudinal sample publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2017.06.964 – volume: 22 start-page: 39 year: 2015 end-page: 57 ident: CR72 article-title: Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies publication-title: Ageing Res Rev doi: 10.1016/j.arr.2015.04.006 – volume: 25 start-page: 345 year: 2015 end-page: 354 ident: CR41 article-title: Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans publication-title: Ethn Dis doi: 10.18865/ed.25.3.345 – volume: 59 start-page: 378 year: 2002 end-page: 384 ident: CR48 article-title: Serum lipoprotein levels, statin use, and cognitive function in older women publication-title: Arch Neurol doi: 10.1001/archneur.59.3.378 – volume: 13 start-page: 817 year: 2013 end-page: 824 ident: CR32 article-title: Association of statin use with risk of dementia: a meta-analysis of prospective cohort studies publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.12044 – volume: 63 start-page: 1435 year: 2015 end-page: 1442 ident: CR76 article-title: Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13482 – volume: 9 start-page: e88434 year: 2014 ident: CR38 article-title: Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan publication-title: PLoS One doi: 10.1371/journal.pone.0088434 – volume: 416 start-page: 279 year: 2007 end-page: 284 ident: CR47 article-title: Cholesterol level, statin use and Alzheimer’s disease in adults with Down syndrome publication-title: Neurosci Lett doi: 10.1016/j.neulet.2007.02.023 – volume: 71 start-page: 344 year: 2008 end-page: 350 ident: CR9 article-title: Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study publication-title: Neurology doi: 10.1212/01.wnl.0000319647.15752.7b – volume: 361 start-page: 1149 year: 2003 end-page: 1158 ident: CR58 article-title: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(03)12948-0 – volume: 15 start-page: 1285 year: 2016 end-page: 1294 ident: CR4 article-title: Research priorities to reduce the global burden of dementia by 2025 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(16)30235-6 – volume: 7 start-page: 270 year: 2011 end-page: 279 ident: CR81 article-title: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2011.03.008 – volume: 32 start-page: 743 year: 2015 end-page: 754 ident: CR40 article-title: Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study publication-title: Drugs Aging doi: 10.1007/s40266-015-0295-4 – volume: 65 start-page: 949 year: 2011 end-page: 957 ident: CR42 article-title: Statins and serum cholesterol’s associations with incident dementia and mild cognitive impairment publication-title: J Epidemiol Community Health doi: 10.1136/jech.2009.100826 – volume: 50 start-page: 1852 year: 2002 end-page: 1856 ident: CR15 article-title: Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2002.50515.x – volume: 71 start-page: 341 year: 2015 end-page: 355 ident: CR69 article-title: Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect? publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-014-1801-z – volume: 62 start-page: 217 year: 2005 end-page: 224 ident: CR25 article-title: Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.62.2.217 – year: 2017 ident: CR73 article-title: Exercise training for preventing dementia, mild cognitive impairment, and clinically meaningful cognitive decline: a systematic review and meta-analysis publication-title: J Gerontol A Biol Sci Med Sci – volume: 13 start-page: 1 year: 2017 end-page: 7 ident: CR3 article-title: The worldwide costs of dementia 2015 and comparisons with 2010 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.07.150 – volume: 329 start-page: 264 year: 2016 end-page: 274 ident: CR6 article-title: Simvastatin inhibits protein isoprenylation in the brain publication-title: Neuroscience doi: 10.1016/j.neuroscience.2016.04.053 – volume: 22 start-page: 345 year: 2013 end-page: 358 ident: CR34 article-title: Statins in the prevention of dementia and Alzheimer’s disease: a meta-analysis of observational studies and an assessment of confounding publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3381 – volume: 74 start-page: 225 year: 2017 end-page: 232 ident: CR65 article-title: Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.3783 – volume: 62 start-page: 1047 year: 2005 end-page: 1051 ident: CR22 article-title: Statin use and the risk of incident dementia: the Cardiovascular Health Study publication-title: Arch Neurol doi: 10.1001/archneur.62.7.1047 – volume: 61 start-page: 1449 year: 2013 end-page: 1455 ident: CR54 article-title: Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment publication-title: J Am Geriatr Soc doi: 10.1111/jgs.12414 – volume: 120 start-page: 706 year: 2007 end-page: 712 ident: CR84 article-title: Impact of statin dosing intensity on transaminase and creatine kinase publication-title: Am J Med doi: 10.1016/j.amjmed.2006.07.033 – volume: 57 start-page: 173 year: 2005 end-page: 185 ident: CR63 article-title: The blood-brain barrier/neurovascular unit in health and disease publication-title: Pharmacol Rev doi: 10.1124/pr.57.2.4 – volume: 8 start-page: 890 year: 2001 end-page: 899 ident: CR59 article-title: A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease publication-title: Neurobiol Dis doi: 10.1006/nbdi.2001.0422 – volume: 6 start-page: 360 year: 2006 end-page: 374 ident: CR67 article-title: Clinical implications of pharmacogenomics of statin treatment publication-title: Pharmacogenomics J doi: 10.1038/sj.tpj.6500384 – volume: 26 start-page: 749 year: 2011 end-page: 757 ident: CR44 article-title: Risk factors for dementia in patients over 65 with diabetes publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.2604 – volume: 159 start-page: 688 year: 2013 end-page: 697 ident: CR37 article-title: Statins and cognitive function: a systematic review publication-title: Ann Intern Med doi: 10.7326/0003-4819-159-10-201311190-00007 – ident: CR78 – volume: 80 start-page: 13 year: 2009 end-page: 17 ident: CR10 article-title: Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2008.150433 – volume: 21 start-page: 436 year: 2012 end-page: 444 ident: CR8 article-title: Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002 – volume: 34 start-page: 939 year: 1984 end-page: 944 ident: CR79 article-title: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease publication-title: Neurology doi: 10.1212/WNL.34.7.939 – volume: 283 start-page: 3230 year: 2000 end-page: 3235 ident: CR27 article-title: Treating nondementia illnesses in patients with dementia publication-title: JAMA doi: 10.1001/jama.283.24.3230 – volume: 8 start-page: 103 year: 2013 end-page: 110 ident: CR61 article-title: Atorvastatin attenuates the production of IL-1beta, IL-6, and TNF-alpha in the hippocampus of an amyloid beta1-42-induced rat model of Alzheimer’s disease publication-title: Clin Interv Aging – volume: 93 start-page: 94 year: 2018 end-page: 102 ident: CR30 article-title: Interpretation of epidemiologic studies very often lacked adequate consideration of confounding publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2017.09.013 – volume: 360 start-page: 7 year: 2002 end-page: 22 ident: CR56 article-title: G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(02)09327-3 – volume: 20 start-page: 925 year: 2010 end-page: 933 ident: CR5 article-title: Can statins prevent or help treat Alzheimer’s disease? publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-091570 – volume: 2 start-page: e18 year: 2005 ident: CR7 article-title: Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK publication-title: PLoS Med doi: 10.1371/journal.pmed.0020018 – volume: 185 start-page: 78 year: 2006 end-page: 86 ident: CR26 article-title: Statin therapy in Alzheimer’s disease publication-title: Acta Neurol Scand Suppl doi: 10.1111/j.1600-0404.2006.00689.x – volume: 64 start-page: 223 year: 2016 end-page: 224 ident: CR39 article-title: Statin Therapy and Dementia in Older Adults: Role of Disease Severity and Multimorbidity publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13907 – volume: 39 start-page: S253 year: 2016 end-page: 259 ident: CR75 article-title: Remembering Statins: Do Statins Have Adverse Cognitive Effects? publication-title: Diabetes Care doi: 10.2337/dcS15-3022 – volume: 59 start-page: 223 year: 2002 end-page: 227 ident: CR14 article-title: Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people publication-title: Arch Neurol doi: 10.1001/archneur.59.2.223 – volume: 5 year: 2007 ident: CR49 article-title: Simvastatin is associated with a reduced incidence of dementia and Parkinson’s disease publication-title: BMC Med doi: 10.1186/1741-7015-5-20 – volume: 11 start-page: 193 year: 2006 end-page: 206 ident: CR83 article-title: Assessing heterogeneity in meta-analysis: Q statistic or I2 index? publication-title: Psychol Methods doi: 10.1037/1082-989X.11.2.193 – ident: CR2 – volume: 59 start-page: 819 year: 2006 end-page: 828 ident: CR28 article-title: Selective prescribing led to overestimation of the benefits of lipid-lowering drugs publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2005.12.012 – volume: 57 start-page: M414 year: 2002 end-page: 418 ident: CR11 article-title: The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/57.7.M414 – volume: 9 start-page: 10 year: 2017 ident: CR29 article-title: Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0237-y – volume: 5 start-page: 292 year: 2009 ident: CR46 article-title: Statins and dementia prevention: A population-based study (FINRISK) publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2009.04.415 – ident: CR82 – volume: 58 start-page: 1311 year: 2010 end-page: 1317 ident: CR13 article-title: Age-varying association between statin use and incident Alzheimer’s disease publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2010.02906.x – volume: 67 start-page: 99 year: 2009 end-page: 109 ident: CR24 article-title: Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2008.03308.x – volume: 30 start-page: 348 year: 2015 end-page: 358 ident: CR52 article-title: Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials publication-title: J Gen Intern Med doi: 10.1007/s11606-014-3115-3 – volume: 203-204 start-page: 195 year: 2002 end-page: 197 ident: CR55 article-title: Plasma antioxidant activity and vascular dementia publication-title: J Neurol Sci doi: 10.1016/S0022-510X(02)00290-3 – volume: 30 start-page: 629 year: 2012 end-page: 637 ident: CR18 article-title: Lipid lowering agents, cognitive decline, and dementia: the three-city study publication-title: J Alzheimers Dis – volume: 340 start-page: c2197 year: 2010 ident: CR43 article-title: Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database publication-title: BMJ doi: 10.1136/bmj.c2197 – volume: 315 start-page: 629 year: 1997 end-page: 634 ident: CR86 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 21 start-page: 927 year: 2017 end-page: 932 ident: CR74 article-title: Measurements of Daily Energy Intake and Total Energy Expenditure in People with Dementia in Care Homes: The Use of Wearable Technology publication-title: J Nutr Health Aging doi: 10.1007/s12603-017-0870-y – volume: 23 start-page: 94 year: 2004 end-page: 98 ident: CR17 article-title: Association between statin use and Alzheimer’s disease publication-title: Neuroepidemiology doi: 10.1159/000073981 – volume: 61 start-page: 705 year: 2004 end-page: 714 ident: CR23 article-title: Relation of plasma lipids to Alzheimer disease and vascular dementia publication-title: Arch Neurol doi: 10.1001/archneur.61.5.705 – volume: 35 start-page: S3 issue: Suppl 2 year: 2014 end-page: 10 ident: CR70 article-title: Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer’s disease publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2014.03.037 – volume: 9 start-page: 65 issue: Suppl 1 year: 1997 end-page: 69 ident: CR80 article-title: Aging, memory, and mild cognitive impairment publication-title: Int Psychogeriatr doi: 10.1017/S1041610297004717 – volume: 70 start-page: 1795 year: 2008 end-page: 1802 ident: CR19 article-title: Statins, incident Alzheimer disease, change in cognitive function, and neuropathology publication-title: Neurology doi: 10.1212/01.wnl.0000288181.00826.63 – volume: 69 start-page: 878 year: 2007 end-page: 885 ident: CR51 article-title: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease publication-title: Neurology doi: 10.1212/01.wnl.0000277657.95487.1c – volume: 63 start-page: 1624 year: 2004 end-page: 1628 ident: CR21 article-title: Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study publication-title: Neurology doi: 10.1212/01.WNL.0000142963.90204.58 – volume: 23 start-page: 194 year: 2007 end-page: 201 ident: CR35 article-title: Prevention and treatment of dementia or Alzheimer’s disease by statins: a meta-analysis publication-title: Dement Geriatr Cogn Disord doi: 10.1159/000099037 – volume: 71 start-page: 329 year: 2015 end-page: 340 ident: CR68 article-title: Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-014-1800-0 – volume: 19 start-page: 666 year: 2017 end-page: 671 ident: CR85 article-title: Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review publication-title: Asian J Androl doi: 10.4103/1008-682X.168687 – volume: 12 year: 2014 ident: CR53 article-title: Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis publication-title: BMC Med doi: 10.1186/1741-7015-12-51 – volume: 22 start-page: 392 year: 2006 end-page: 398 ident: CR64 article-title: Statins of different brain penetrability differentially affect CSF PLTP activity publication-title: Dement Geriatr Cogn Disord doi: 10.1159/000095679 – volume: 21 start-page: 95 year: 2010 end-page: 102 ident: CR20 article-title: Statins and cognitive functioning in the elderly: a population-based study publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-100180 – volume: 6 start-page: e1000100 year: 2009 ident: CR77 article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: PLoS Med doi: 10.1371/journal.pmed.1000100 – volume: 6 start-page: 4452 year: 2014 end-page: 4471 ident: CR71 article-title: Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? publication-title: Nutrients doi: 10.3390/nu6104452 – year: 2017 ident: CR66 article-title: Comparative effect of statins on the risk of incident Alzheimer disease publication-title: Neurology – volume: 88 start-page: 1213 year: 2013 end-page: 1221 ident: CR33 article-title: Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2013.07.013 – volume: 360 start-page: 1623 year: 2002 end-page: 1630 ident: CR57 article-title: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(02)11600-X – volume: 5 start-page: 416 year: 2008 end-page: 421 ident: CR16 article-title: Reduced risk of incident AD with elective statin use in a clinical trial cohort publication-title: Curr Alzheimer Res doi: 10.2174/156720508785132316 – volume: 69 start-page: 1873 year: 2007 end-page: 1880 ident: CR50 article-title: Association of statin use with cognitive decline in elderly African Americans publication-title: Neurology doi: 10.1212/01.wnl.0000279333.77404.d7 – volume: 120 start-page: 229 year: 2017 end-page: 243 ident: CR62 article-title: Pleiotropic Effects of Statins on the Cardiovascular System publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.308537 – volume: 5 start-page: e13 year: 2009 end-page: e14 ident: CR45 article-title: Statin use is not associated with cognitive impairment in a cohort of older women publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2009.07.067 – volume: 5 start-page: 416 year: 2008 ident: 24248_CR16 publication-title: Curr Alzheimer Res doi: 10.2174/156720508785132316 – volume: 57 start-page: M414 year: 2002 ident: 24248_CR11 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/57.7.M414 – volume: 9 start-page: 10 year: 2017 ident: 24248_CR29 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0237-y – volume: 39 start-page: S253 year: 2016 ident: 24248_CR75 publication-title: Diabetes Care doi: 10.2337/dcS15-3022 – volume: 30 start-page: 348 year: 2015 ident: 24248_CR52 publication-title: J Gen Intern Med doi: 10.1007/s11606-014-3115-3 – volume: 64 start-page: 223 year: 2016 ident: 24248_CR39 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13907 – volume: 30 start-page: 629 year: 2012 ident: 24248_CR18 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2012-120064 – volume: 6 start-page: 4452 year: 2014 ident: 24248_CR71 publication-title: Nutrients doi: 10.3390/nu6104452 – volume: 23 start-page: 194 year: 2007 ident: 24248_CR35 publication-title: Dement Geriatr Cogn Disord doi: 10.1159/000099037 – volume: 6 start-page: 360 year: 2006 ident: 24248_CR67 publication-title: Pharmacogenomics J doi: 10.1038/sj.tpj.6500384 – volume: 63 start-page: 1624 year: 2004 ident: 24248_CR21 publication-title: Neurology doi: 10.1212/01.WNL.0000142963.90204.58 – volume: 11 start-page: 193 year: 2006 ident: 24248_CR83 publication-title: Psychol Methods doi: 10.1037/1082-989X.11.2.193 – ident: 24248_CR82 – volume: 20 start-page: 925 year: 2010 ident: 24248_CR5 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-091570 – volume: 9 start-page: e88434 year: 2014 ident: 24248_CR38 publication-title: PLoS One doi: 10.1371/journal.pone.0088434 – volume: 13 start-page: 817 year: 2013 ident: 24248_CR32 publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.12044 – volume: 93 start-page: 94 year: 2018 ident: 24248_CR30 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2017.09.013 – volume: 159 start-page: 688 year: 2013 ident: 24248_CR37 publication-title: Ann Intern Med doi: 10.7326/0003-4819-159-10-201311190-00007 – volume: 416 start-page: 279 year: 2007 ident: 24248_CR47 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2007.02.023 – volume: 21 start-page: 95 year: 2010 ident: 24248_CR20 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-100180 – volume: 283 start-page: 3230 year: 2000 ident: 24248_CR27 publication-title: JAMA doi: 10.1001/jama.283.24.3230 – volume: 59 start-page: 223 year: 2002 ident: 24248_CR14 publication-title: Arch Neurol doi: 10.1001/archneur.59.2.223 – ident: 24248_CR78 – volume: 62 start-page: 217 year: 2005 ident: 24248_CR25 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.62.2.217 – volume: 70 start-page: 1795 year: 2008 ident: 24248_CR19 publication-title: Neurology doi: 10.1212/01.wnl.0000288181.00826.63 – volume: 283 start-page: 230 year: 2009 ident: 24248_CR60 publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.02.352 – volume: 356 start-page: 1627 year: 2000 ident: 24248_CR12 publication-title: Lancet doi: 10.1016/S0140-6736(00)03155-X – year: 2017 ident: 24248_CR66 publication-title: Neurology doi: 10.1212/WNL.0000000000004818 – volume: 67 start-page: 99 year: 2009 ident: 24248_CR24 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2008.03308.x – volume: 25 start-page: 345 year: 2015 ident: 24248_CR41 publication-title: Ethn Dis doi: 10.18865/ed.25.3.345 – volume: 2 start-page: e18 year: 2005 ident: 24248_CR7 publication-title: PLoS Med doi: 10.1371/journal.pmed.0020018 – volume: 5 year: 2007 ident: 24248_CR49 publication-title: BMC Med doi: 10.1186/1741-7015-5-20 – volume: 22 start-page: 392 year: 2006 ident: 24248_CR64 publication-title: Dement Geriatr Cogn Disord doi: 10.1159/000095679 – volume: 32 start-page: 743 year: 2015 ident: 24248_CR40 publication-title: Drugs Aging doi: 10.1007/s40266-015-0295-4 – volume: 62 start-page: 1047 year: 2005 ident: 24248_CR22 publication-title: Arch Neurol doi: 10.1001/archneur.62.7.1047 – volume: 5 start-page: 292 year: 2009 ident: 24248_CR46 publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2009.04.415 – volume: 203-204 start-page: 195 year: 2002 ident: 24248_CR55 publication-title: J Neurol Sci doi: 10.1016/S0022-510X(02)00290-3 – volume: 88 start-page: 1213 year: 2013 ident: 24248_CR33 publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2013.07.013 – volume: 58 start-page: 1311 year: 2010 ident: 24248_CR13 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2010.02906.x – volume: 22 start-page: 345 year: 2013 ident: 24248_CR34 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3381 – volume: 6 start-page: e1000100 year: 2009 ident: 24248_CR77 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000100 – volume: 22 start-page: 39 year: 2015 ident: 24248_CR72 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2015.04.006 – volume: 8 start-page: 103 year: 2013 ident: 24248_CR61 publication-title: Clin Interv Aging doi: 10.2147/CIA.S40405 – volume: 340 start-page: c2197 year: 2010 ident: 24248_CR43 publication-title: BMJ doi: 10.1136/bmj.c2197 – volume: 120 start-page: 229 year: 2017 ident: 24248_CR62 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.308537 – volume: 71 start-page: 341 year: 2015 ident: 24248_CR69 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-014-1801-z – volume: 71 start-page: 329 year: 2015 ident: 24248_CR68 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-014-1800-0 – volume: 61 start-page: 1449 year: 2013 ident: 24248_CR54 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.12414 – volume: 329 start-page: 264 year: 2016 ident: 24248_CR6 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2016.04.053 – volume: 35 start-page: S3 issue: Suppl 2 year: 2014 ident: 24248_CR70 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2014.03.037 – volume: 120 start-page: 706 year: 2007 ident: 24248_CR84 publication-title: Am J Med doi: 10.1016/j.amjmed.2006.07.033 – volume: 8 start-page: 890 year: 2001 ident: 24248_CR59 publication-title: Neurobiol Dis doi: 10.1006/nbdi.2001.0422 – volume: 23 start-page: 726 year: 2003 ident: 24248_CR31 publication-title: Pharmacotherapy doi: 10.1592/phco.23.6.726.32184 – volume: 50 start-page: 1852 year: 2002 ident: 24248_CR15 publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2002.50515.x – volume: 65 start-page: 949 year: 2011 ident: 24248_CR42 publication-title: J Epidemiol Community Health doi: 10.1136/jech.2009.100826 – volume: 315 start-page: 629 year: 1997 ident: 24248_CR86 publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – ident: 24248_CR2 – volume: 57 start-page: 173 year: 2005 ident: 24248_CR63 publication-title: Pharmacol Rev doi: 10.1124/pr.57.2.4 – volume: 8 start-page: 23 year: 2016 ident: 24248_CR1 publication-title: Alzheimers Res Ther doi: 10.1186/s13195-016-0188-8 – volume: 59 start-page: 378 year: 2002 ident: 24248_CR48 publication-title: Arch Neurol doi: 10.1001/archneur.59.3.378 – volume: 360 start-page: 7 year: 2002 ident: 24248_CR56 publication-title: Lancet doi: 10.1016/S0140-6736(02)09327-3 – volume: 5 start-page: e13 year: 2009 ident: 24248_CR45 publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2009.07.067 – volume: 74 start-page: 225 year: 2017 ident: 24248_CR65 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.3783 – volume: 15 start-page: 1285 year: 2016 ident: 24248_CR4 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(16)30235-6 – volume: 21 start-page: 436 year: 2012 ident: 24248_CR8 publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002 – volume: 26 start-page: 749 year: 2011 ident: 24248_CR44 publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.2604 – volume: 69 start-page: 1873 year: 2007 ident: 24248_CR50 publication-title: Neurology doi: 10.1212/01.wnl.0000279333.77404.d7 – volume: 61 start-page: 705 year: 2004 ident: 24248_CR23 publication-title: Arch Neurol doi: 10.1001/archneur.61.5.705 – volume: 13 start-page: 1 year: 2017 ident: 24248_CR3 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.07.150 – volume: 21 start-page: 927 year: 2017 ident: 24248_CR74 publication-title: J Nutr Health Aging doi: 10.1007/s12603-017-0870-y – volume: 71 start-page: 344 year: 2008 ident: 24248_CR9 publication-title: Neurology doi: 10.1212/01.wnl.0000319647.15752.7b – volume: 7 start-page: 270 year: 2011 ident: 24248_CR81 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2011.03.008 – year: 2017 ident: 24248_CR73 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glx234 – volume: 13 start-page: 736 year: 2017 ident: 24248_CR36 publication-title: Alzheimer’s & Dementia doi: 10.1016/j.jalz.2017.06.964 – volume: 69 start-page: 878 year: 2007 ident: 24248_CR51 publication-title: Neurology doi: 10.1212/01.wnl.0000277657.95487.1c – volume: 19 start-page: 666 year: 2017 ident: 24248_CR85 publication-title: Asian J Androl doi: 10.4103/1008-682X.168687 – volume: 9 start-page: 65 issue: Suppl 1 year: 1997 ident: 24248_CR80 publication-title: Int Psychogeriatr doi: 10.1017/S1041610297004717 – volume: 63 start-page: 1435 year: 2015 ident: 24248_CR76 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13482 – volume: 12 year: 2014 ident: 24248_CR53 publication-title: BMC Med doi: 10.1186/1741-7015-12-51 – volume: 23 start-page: 94 year: 2004 ident: 24248_CR17 publication-title: Neuroepidemiology doi: 10.1159/000073981 – volume: 360 start-page: 1623 year: 2002 ident: 24248_CR57 publication-title: Lancet doi: 10.1016/S0140-6736(02)11600-X – volume: 34 start-page: 939 year: 1984 ident: 24248_CR79 publication-title: Neurology doi: 10.1212/WNL.34.7.939 – volume: 185 start-page: 78 year: 2006 ident: 24248_CR26 publication-title: Acta Neurol Scand Suppl doi: 10.1111/j.1600-0404.2006.00689.x – volume: 59 start-page: 819 year: 2006 ident: 24248_CR28 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2005.12.012 – volume: 80 start-page: 13 year: 2009 ident: 24248_CR10 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2008.150433 – volume: 361 start-page: 1149 year: 2003 ident: 24248_CR58 publication-title: Lancet doi: 10.1016/S0140-6736(03)12948-0 |
SSID | ssj0000529419 |
Score | 2.5514996 |
SecondaryResourceType | review_article |
Snippet | We conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia,... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5804 |
SubjectTerms | 692/308/174 692/499 Alzheimer's disease Cognitive ability Dementia Dementia disorders Humanities and Social Sciences Lipophilic Meta-analysis multidisciplinary Risk assessment Science Science (multidisciplinary) Statins Systematic review Vascular dementia |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7SlEAvpa-0TtKiQm-tyMovSb2EUBpCIT11YW9GLxPD1pvGm0P_fWdkrZdtSK6WhGzPSPpmRvMNwCeja1-0zvLW1IaXQdXcWi15VUlh0ShyPoYLrn7Wl_Pyx6JaJIfbkK5VbvbEuFH7lSMfORnpxKEqpTy7-cOpahRFV1MJjSfwlKjLSKvlQk4-FopilUKnXJlZoU4HPK8op0woioWWiqvd8-geyLx_V_K_gGk8hy5ewPMEINn5KPGXsBf6V3AwlpT8-xqW8yGwVcsoUajrB2Z6zxDjMbpCTs99dAd2Jjb87paeTReIGGVMdrfU_pWdsy3HMxvzW8YhYW24SUwmb2B-8f3Xt0ueKipwh8hszYNRM48QC22yHLGJK6wtpfQ1nmOI86qZk9oJbWfCEwu8DUHXwuq2yg0io6LWxSHs96s-vAOmLSKF2iAaaFVZFblRaNqJ1rfaO2-UzkBs_mvjEt04Vb1YNjHsXahmlEWDsmiiLBqVwedpzM1ItvFo75ONuJq08IZmqyYZfJyacclQHMT0YXUX-5QlGWJ5Bm9H6U7TURSakmszkDtynzoQHfduS99dR1ruSlGSMM77ZaMh29d6-CuOHv-KY3iWk7YSu6Q4gf317V14jzBobT9EXf8H3twEhw priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7xEBKXqi2FpqXISNyoxTov272tEAitRC-wErfIjh0RaclWu8uh_74zzgNteUhcM7aceOz4s2e-zwAnRucuqUrLK5MbnnqVc2u15FkmhcVNUelCuOD6d341TSd32d0GxD0XJiTtB0nL8Jvus8POlrjQEBlMKApipoqrTdgmqXYc29vj8eRmMpysUOwqFbpjyIwS9ULl9VXoGbR8niH5X5g0rD6XH-FDBxvZuH3RT7Dhm8-w014k-XcPZtOlZ_OKET2obpbMNI4hsmOUOE7PXTgErE0wPNQzx4a0IUY8yXpB9l9szJ6UnVnLammr-JXhptMv-QLTy4vb8yve3aPAS8RjK-6NGjkEVrgTixGRlIm1qZQux9UL0V02KqUuhbYj4Uj73Xqvc2F1lcUG8VCS62Qftpp5478C0xbxQW4QA1QK-z42Cjd0onKVdqUzSkcg-n4tyk5knO66mBUh2J2oovVFgb4ogi8KFcHpUOdPK7HxZunD3l1FN92WRRwourGUMoLjwYwThaIfpvHzx1AmTWn7FUdw0Hp3aI5iz0SpjUCu-X0oQCLc65amvg9i3JkiajC2-7MfIU-v9fpXfHtf8e-wG9PoJY1JcQhbq8Wj_4FgaGWPutH_D7XdA7Y priority: 102 providerName: Springer Nature |
Title | Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis |
URI | https://link.springer.com/article/10.1038/s41598-018-24248-8 https://www.ncbi.nlm.nih.gov/pubmed/29643479 https://www.proquest.com/docview/2023992777 https://www.proquest.com/docview/2024474392 https://pubmed.ncbi.nlm.nih.gov/PMC5895617 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFD7sBcEX8W51HSL4ptVJb0kEkXHYZRnYRdSBeStJk2Jh7OjMLLj_3nOStsu4q-BToUno5SSc7-Tk-w7AS60Km9aViWtd6DhzsoiNUSLOc8ENBkWV9emCs_PidJ7NFvliD_pyR90P3NwY2lE9qfl6-ebXz8sPuODfB8q4fLtBJ0REMS4pwZnJWO7DIXomQRUNzjq4H7S-E5Vx1XFnbh6665-ugc7rZyf_SKB6v3RyF-50gJJNwgy4B3uuvQ-3QonJywewnG8cW9WMiENNu2G6tQwxH6Mj5XTf-u3BRvuG783SsuFAESMGZbOm9ndswq40n1ngu4Qhbqtj3SmbPIT5yfHX6WncVViIK0Rq29hpObYIuTBGSxCrVKkxmRC2QL-GuC8fV0JVXJkxt6QKb5xTBTeqzhONSCktVPoIDtpV654AUwaRQ6ERHdQyy9NESwz1eG1rZSurpYqA9_-1rDr5caqCsSx9GjyVZbBFibYovS1KGcGrYcyPIL7xz95HvbnKfh6ViSfvJkKICF4MzbiEKC-iW7e68H2yjAKzJILHwbrD4ygrTWTbCMSO3YcOJM-929I237xMdy6JNIzPfd3PkKvX-vtXPP2_7s_gdkKzl9Qn-REcbNcX7jnCpK0Zwb5YiBEcTiazLzO8fjw-__QZ706L6chvPYz86vgNzYUR2A |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQguFW8CBYwEJ7DI2zYSQhVQbenj1JX2FuzYEZG22dJshfqn-hs74zxWS0VvvcaOHGfGnm88nm8A3mmV26QqDa90rnnqZM6NUYJnmYgMOkWl9eGCw6N8Mk1_zrLZBlwOuTB0rXLYE_1GbRclnZGTk04cqkKIr6d_OFWNoujqUEKjU4t9d_EXXbb2y953lO_7ON79cfxtwvuqArxEdLLkTsvQIsxAvyRG-1wmxqRC2Bz3csQ6WVgKVUbKhJElJnTjnMojo6os1ogOkpzIl3DLv4OGNyRnT8zEeKZDUbM0Un1uTpjITy3aR8phiyTFXlPJ5br9uwZqr9_N_CdA6-3e7gPY6gEr2-k07CFsuOYR3O1KWF48hvm0dWxRMUpMqpuW6cYyxJSMrqzTc-uPH2vtG07quWXjhSVGGZr1GbV_ZjtsxSnNunya7hW31Fz3zClPYHor__opbDaLxj0Hpgwik1wj-qhkmiWxluhKRpWtlC2tliqAaPivRdnTm1OVjXnhw-yJLDpZFCiLwsuikAF8GN857cg9buy9PYir6Bd6W6zUMoC3YzMuUYq76MYtzn2fNCXHLw7gWSfdcTiKelMybwBiTe5jB6L_Xm9p6t-eBjyTlJSM434cNGT1Wf-fxYubZ_EG7k2ODw-Kg72j_ZdwPybNJWbLaBs2l2fn7hVCsKV57fWewa_bXmhX0Z8-ZA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB_KFcUX8dvVqhH0SUNvP5MIItX2aK0eRTzoW5pssrhw7tXuFem_5l_nzH4dZ7Fvfd1kyWZnkvwmM_MbgFdGZS4ucssLkxmeeJlxa5XgaSpCi0ZR7hp3wddptj9LPh-nxxvwp8-FobDKfk9sNmq3yOmOnIx04lAVQmwXXVjE0e7kw-kvThWkyNPal9NoVeTQX_xG861-f7CLsn4dRZO975_2eVdhgOeIVJbcGzl2CDnQRonwrM5jaxMhXIb7OuKedJwLlYfKjkNHrOjWe5WFVhVpZBApxBkRMeH2vynIKhrB5se96dG34YaHfGhJqLpMnXEst2s8LSmjLZTkiU0kl-un4SWIezlS8x93bXMKTu7A7Q6-sp1W3-7Chq_uwY22oOXFfZjPas8WBaM0pbKqmakcQ4TJKICdnrvmMrI0TcPPcu7YEL7EKF-zPKP2d2yHrRimWZtd077il4abjkflAcyu5W8_hFG1qPxjYMoiTskMYpFCJmkcGYmGZVi4QrncGakCCPv_qvOO7Jxqbsx143SPpW5loVEWupGFlgG8Gd45bak-ruy91YtLd8u-1islDeDl0IwLlrwwpvKL86ZPkpAZGAXwqJXuMBz5wCm1NwCxJvehA5GBr7dU5Y-GFDyVlKKM477tNWT1Wf-fxZOrZ_ECbuIi018OpodP4VZEiks0l-EWjJZn5_4Z4rGlfd4pPoOT615rfwFfPEP_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+statins+and+the+risk+of+dementia+and+mild+cognitive+impairment%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Scientific+reports&rft.au=Chu%2C+Che-Sheng&rft.au=Tseng%2C+Ping-Tao&rft.au=Stubbs%2C+Brendon&rft.au=Chen%2C+Tien-Yu&rft.date=2018-04-11&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=8&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-018-24248-8&rft.externalDocID=10_1038_s41598_018_24248_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |